AA
KRTX

ALPS Advisors’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

ALPS Advisors’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,271
Closed -$4.11M – 1097
2022
Q3 		$4.11M Buy
18,271
+547
+3% +$111K 0.04% 191
2022
Q2 		$2.24M Sell
17,724
-12,913
-42% -$1.48M 0.02% 300
2022
Q1 		$3.88M Sell
30,637
-3,644
-11% -$410K 0.04% 143
2021
Q4 		$4.49M Sell
34,281
-1,938
-5% -$250K 0.05% 154
2021
Q3 		$4.43M Sell
36,219
-2,478
-6% -$286K 0.04% 182
2021
Q2 		$4.41M Sell
38,697
-13,891
-26% -$1.62M 0.04% 183
2021
Q1 		$6.32M Buy
52,588
+4,481
+9% +$508K 0.06% 163
2020
Q4 		$4.89M Buy
48,107
+14,170
+42% +$1.31M 0.06% 176
2020
Q3 		$2.62M Sell
33,937
-1,711
-5% -$146K 0.04% 201
2020
Q2 		$3.97M Sell
35,648
-11,642
-25% -$1.01M 0.05% 172
2020
Q1 		$3.4M Sell
47,290
-5,118
-10% -$438K 0.05% 172
2019
Q4 		$3.95M Buy
+52,408
New +$2.3M 0.03% 173

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ALPS Advisors's KRTX Position: Q4 2022 in Review

ALPS Advisors sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2022, closing a stake of 18,271 shares — an estimated $4.11M sold.

ALPS Advisors first reported a position in KRTX in Q4 2019 and held it in 12 quarters. The position peaked at $6.32M in Q1 2021. 248 funds tracked by Wall St. Rank hold KRTX as of Q4 2022.

  • ALPS Advisors reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • ALPS Advisors sold 18,271 Karuna Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $4.11M.
  • ALPS Advisors first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • ALPS Advisors's Karuna Therapeutics, Inc. Common Stock position peaked at $6.32M in Q1 2021.
  • 248 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2022.

Based on ALPS Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.